Every year, the pharmaceutical industry spends more than $50 billion on research and development. But the path to drug approval by the Food and Drug Administration is laden with abrupt failures in late-phase testing. Only one in 5,000 drugs will make it to market, according to one estimate.

One small biology company believes it has a solution to the pipeline problem: 3-D printing.

At...